Receive news by e-mail

#
 

Enter your e-mail in the field below to receive directly the news that appears on this page.

 

topics : related - all Explore

Shopping Categories

  1. 1. Cell Phones
  2. 2. Smartphones
  3. 3. Digital Cameras
  4. 4. Laptop Computers
  5. 5. Processors
  6. 6. Motherboards
  7. 7. LCD Monitors
  8. 8. Graphics Cards
  9. 9. GPS
  10. 10. Digital Camcorders
  11. 11. Printers
  12. 12. Desktop Computers
  13. 13. Sedans
  14. 14. Coupes & Convertibles
  15. 15. 4x4

Wikio Shopping

  1. 1. Automotive
  2. 2. Beauty & Fragrances
  3. 3. Books
  4. 4. Car/Motorbike
  5. 5. CD
  6. 6. Clothing, Accessories & Shoes
  7. 7. Communication
  8. 8. Computers
  9. 9. DVD
  10. 10. Electronics
  11. 11. Flowers & Gifts
  12. 12. Gourmet & Foods
  13. 13. Health & Personal Care
  14. 14. Home & Garden
  15. 15. Hotels
  16. 16. Household Appliances
  17. 17. Jewelry & Watches
  18. 18. Musical Instruments
  19. 19. Sports & Outdoors
  20. 20. Toys & Baby
  21. 21. Video Games

Participate



Novo Nordisk



Sort by : relevance - date - popularity
7Vote!

Stays Pending Appeal

Novo Nordisk v. Caraco Pharma (Fed. Cir. 2009) Unlike most interlocutory orders, the grant or denial of preliminary injunctive relief may be immediately appealed. A district court only awards preliminary injunctive relief after determining that the moving party is likely...

6Vote!

Pharma earnings recap: Mylan, Allergan, Novo-Nordisk

Filed under: Earnings reports , Allergan (AGN) One would expect generic U.S. drugmaker Mylan (NYSE: MYL ) to benefit from all this talk about increased generic competitions, but revenue only increased 5.2 percent to $1.26 billion on an operational basis, beating analyst revenue estimates of $1.23 billion. Still, revenue in North America, where most pharmas have been hurting, rose 9.2 percent to $502.5...

6Vote!

Novo Nordisk A/S: Novo Nordisk A/S: Director/PDMR Shareholding

BAGSVAERD, DENMARK (MARKET WIRE) Trading in Novo Nordisk shares by board members, executives and associated persons as reported to Novo Nordisk on 29 October 2009

4Vote!

Novo Nordisk is Changing Possibilities in Hemophilia

PRINCETON, N.J., Oct. 30 /PRNewswire-FirstCall/ -- Novo Nordisk Inc. announced the re-launch of its changing possibilities in hemophilia(TM) campaign through a rebranded Web site and a new community on Facebook®. People living with hemophilia face many daily challenges, and Novo Nordisk is committed to helping this community realize that there is also a lifetime of possibilities.

5Vote!

Novo Nordisk is Changing Possibilities in Hemophilia

PRINCETON, N.J., Oct. 30 /PRNewswire-FirstCall/ -- Novo Nordisk Inc. announced the re-launch of its changing possibilities in hemophilia(TM) campaign through a rebranded Web site and a new community on Facebook®.

3Vote!

Lab Group Recognizes The National Changing Diabetes Program For New Study On Quality Measures In Diabetes

The American Clinical Laboratory Association's Results for Life Campaign (RFL) recognized the National Changing Diabetes Program (NCDP) for funding a newly published study on quality measurement in diabetes care. The NCDP, funded by Novo Nordisk, is a multi-faceted initiative to help bring about dramatic improvement in the prevention and care of diabetes.

3Vote!

Novo Nordisk re-launches hemophilia campaign

Princeton company aims to replicate success of diabetes treatment for different condition.

4Vote!

Lab Group Recognizes the National Changing Diabetes Program for New Study on Quality Measures in Diabetes

WASHINGTON, Oct. 29 /PRNewswire-USNewswire/ -- The American Clinical Laboratory Association's Results for Life Campaign (RFL) today recognized the National Changing Diabetes Program (NCDP) for funding a newly published study on quality measurement in diabetes care. The NCDP, funded by Novo Nordisk, is a multi-faceted initiative to help bring about dramatic improvement in the prevention and care of...

4Vote!

Financial Reports: Novo Nordisk 3Q

Novo Nordisk 3Q09 3Q Revenues: $2.5 billion (+11%) 3Q Earnings: $539.7 million (+3%) YTD Revenues: $7.4 billion (+16%) YTD Earnings: $1.7 million (+21%) Comments: In the quarter, Diabetes care sales were $1.8 billion (+12%). Biopharmaceutical sales were $636.3 (+10%). NovoSeven sales were up 8%, Norditropin sales were up 14%, and Hormone replacement therapy sales were up 12%. North America sales were...

7Vote!

Novo Nordisk Q3 profit up 3 pct, raises outlook

Danish drug maker Novo Nordisk A/S, the world's top producer of insulin, on Thursday said stronger sales helped boost its third-quarter profit by 3 percent and raised its full-year outlook.

4Vote!

Novo Nordisk Announces First Nine Months 2009 Results, Operating Profit Up 30%

Danish pharmaceutical company Novo Nordisk reported a 30% increase in operating profit in the first nine months of 2009 to DKK 11,714 (USD 2,326) million compared to DKK 8,999 (USD 1,787) million

5Vote!

Novo Nordisk A/S: 3rd Quarter Results

BAGSVAERD, DENMARK (MARKET WIRE) Interim financial report for the period 1 January 2009 to 30 September 2009

3Vote!

Novo Nordisk ups 2009 EBIT outlook after Q3 rise

COPENHAGEN, Oct 29 (Reuters) - The world's biggest insulin producer Novo Nordisk reported a bigger-than-forecast increase in operating profits for the third quarter and raised its guidance for 2009 profit growth.

10Vote!

Medical device design: NovoTwist wins Good Design Award

Danish medical device company Novo Nordisk has won a Good Design Award for their FlexPen insulin delivery device, which incorporates a needle with a twist--literally: The NovoTwist removeable needle twist-snaps on and off, making it easy for the elderly to swap them out. "Conventional screw thread needles can be difficult to attach and detach, especially for the elderly, as limited manual dexterity...

3Vote!

Danish firm grows R&D for diabetes

With 86 years of history and around three-fourths of its business engaged in diabetes care, Novo Nordisk maintains more than 50 percent of the insulin market by volume around the world, thanks to its focused strategy. The Denmark-based company said that it will continue this approach in China, which is its fastest-growing market. "We have made a long-term strategic commitment to China, from building...